Today: 21 May 2026
MercadoLibre stock ticks up after-hours as fresh SEC filing shows $238 mln fund stake — what to watch next (MELI)
22 January 2026
1 min read

MercadoLibre stock ticks up after-hours as fresh SEC filing shows $238 mln fund stake — what to watch next (MELI)

New York, Jan 21, 2026, 19:19 EST — After-hours

Shares of MercadoLibre (MELI.O) climbed roughly 1% to $2,057.77 in after-hours trading Wednesday, following an intraday range between $2,023.03 and $2,093. About 943,000 shares changed hands.

A quarterly filing with the U.S. Securities and Exchange Commission revealed that Sydney-based Northcape Capital Pty Ltd owned 116,848 shares of MercadoLibre, valued at roughly $238.4 million at the close of 2025.

The filing hit amid investors seeking a clearer sense of risk appetite following two days dominated by tariff news. Wall Street bounced back Wednesday after U.S. President Donald Trump said he wouldn’t slap tariffs over the Greenland dispute. “What is the economic impact is whether we all start imposing tariffs on each other,” said Jason Pride, chief of investment strategy and research at Glenmede. Reuters

Shares tied to Latin America also saw gains. Nu Holdings climbed roughly 1.8%, StoneCo added about 2.6%, and Amazon remained mostly flat.

Form 13F reports provide a backward-looking view of U.S.-listed equity holdings by major money managers, usually submitted weeks after each quarter closes. They don’t reflect the investor’s most recent moves.

MercadoLibre operates an online marketplace and the Mercado Pago payments platform, plus logistics and various other services supporting its commerce and fintech ecosystem.

MELI has shown some volatility this week, dropping 1.9% on Tuesday before rebounding 1.1% on Wednesday, according to daily closing prices.

After-hours shifts often flip as soon as the market reopens. For MercadoLibre, key challenges remain consumer demand, currency volatility, and credit performance in its various markets.

The next milestones are coming up fast. MercadoLibre will hold a fireside chat with Fernando Yunes on Jan. 27 at the UBS Latin America conference in São Paulo. The company also set Feb. 24 as a tentative date to release its fourth-quarter results.

Stock Market Today

  • SpaceX Set to Go Public: Key Details and Market Impact
    May 20, 2026, 8:02 PM EDT. SpaceX, founded by Elon Musk, is poised to go public, joining hundreds of companies that raised $70 billion in U.S. equity markets last year. Going public means the company will offer shares for sale on stock exchanges, allowing investors to buy ownership stakes. This move could unlock significant capital for SpaceX's ambitious space ventures, while providing early investors a chance to realize gains. The offering is closely watched amid a strong appetite for tech and aerospace stocks, reflecting broader market interest in innovation-driven firms.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Applied Materials stock rebounds after tariff scare fades; what to watch next for AMAT
Previous Story

Applied Materials stock rebounds after tariff scare fades; what to watch next for AMAT

Applied Digital stock slides, then swings hard as new Buy call pegs $42 target — what’s next for APLD
Next Story

Applied Digital stock slides, then swings hard as new Buy call pegs $42 target — what’s next for APLD

Go toTop